Differentiation between the effects of T1 and T2* shortening in contrast-enhanced MRI of the breast

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 2, 1999, Pages 172-176

  Kuperman, Vadim Yu ^a   Alley, Marcus T ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Contrast enhanced MRI; MRI of the breast; T1 and T2* relaxation times

Indexed keywords

GADODIAMIDE; GADOLINIUM CHELATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CASE REPORT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIPOLE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE INTENSIFIER; IMAGE RECONSTRUCTION; INTRADUCTAL CARCINOMA; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; BREAST; BREAST TUMOR; FEASIBILITY STUDY; IMAGE PROCESSING; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY;

ADULT; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING;

EID: 0032587759     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199902)9:2<172::AID-JMRI4>3.0.CO;2-G     Document Type: Article

References (20)

1. Bird R, Wallace T, Yankaskas B. Analysis of cancers missed at screening mammography. Radiology 1992;184:613.
2. Baker LH. Breast cancer detection demonstration project: five-year summary report, CA Cancer J Clin 1982;32:194.
3. Samuels JR, Haffty BG, Lee CH, Fischer DB. Breast conservation therapy in patients with mammographically undetected breast cancers. Radiology 1992;185:425.
4. Sickles EA, Parker SH. Appropriate role of core breast biopsy in management of probably benign lesions. Radiology 1993;188:313.
5. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive prediction value of screening mammography by age and family of breast cancer. JAMA 1993;270:2444.
6. Harms SE, Flaming DP, Hesley KL. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493.
7. Harms SE, Flaming DP, Hesley KL, et al. Fat-suppressed three-dimensional MR imaging of the breast. Radiographies 1993;13:247.
8. Keiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without gadodiamide. Radiology 1989;170:681.
9. Stack JP, Redmond OM, Gold MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with gadodiamide enhancement profiles. Radiology 1990;174:491.
10. Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994;4:477.
11. Su MY, Jao JC, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic gadodiamide enhanced MRI. Magn Reson Med 1994;32:714.
12. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast agents. J Magn Reson Imaging 1997;7:68.
13. th Annual Meeting of the ISMRM, Vancouver, Canada, 1997. p 489.
14. 2*-weighted images during hyperoxia differentiates tumors from normal tissue. Magn Reson Med 1995;33:318-325.
15. Bloembergen N, Purcell EM, Pound RV. Relaxation effects in nuclear magnetic resonance absorption. Physiol Rev 1948;73:679.
16. Haacke EM, Tkach JA. Fast MR imaging techniques and clinical applications. AJR 1990;155:951.
17. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imaging 1993;3:137.
18. 2* changes caused by gadodiamide in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging 1996;6:764-768.
19. th Annual Meeting of the ISMRM, Sydney, Australia, 1998. Vol. 2. p 930.
20. th Annual Meeting of the ISMRM, Sydney, Australia, 1998. Vol. 1. p 98.